Carl Zeiss Meditec AG
AFX: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€73.00 | Cjtthpm | Rmxpxsssj |
Sluggish China and North America Sales Weaken 2024 Numbers but Favorable Long-Term Outlook Remains
Business Strategy and Outlook
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: ophthalmic devices, or OPT, and microsurgery, or MCS.